The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Going viral with cancer immunotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Self-citationNecroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
Kaczmarek, A., Vandenabeele, P., & Krysko, D. V. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.003 · Cited by 1,411
Pule, M. A., Savoldo, B., Myers, G. D., Rossig, C., Russell, H. V., Dotti, G., Huls, M. H., Liu, E., Gee, A. P., Mei, Z., et al. (2008) · Nature Medicine · doi:10.1038/nm.1882 · Cited by 1,195
Small, E. J., Schellhammer, P. F., Higano, C. S., Redfern, C. H., Nemunaitis, J. J., Valone, F. H., Verjee, S. S., Jones, L. A., & Hershberg, R. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5252 · Cited by 1,108
Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00241-1 · Cited by 842
Self-citationLiu, B. L., Robinson, M., Han, Z.-Q., Branston, R. H., English, C., Reay, P., McGrath, Y., Thomas, S. K., Thornton, M., Bullock, P., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301885 · Cited by 803
Heo, J., Reid, T., Ruo, L., Breitbach, C. J., Rose, S., Bloomston, M., Cho, M., Lim, H. Y., Chung, H. C., Kim, C. W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3089 · Cited by 779
Self-citationHistory of Oncolytic Viruses: Genesis to Genetic Engineering
Kelly, E., & Russell, S. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300108 · Cited by 763
Zamarin, D., Holmgaard, R. B., Subudhi, S. K., Park, J. S., Mansour, M., Palese, P., Merghoub, T., Wolchok, J. D., & Allison, J. P. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008095 · Cited by 711
Adoptive-cell-transfer therapy for the treatment of patients with cancer
Dudley, M. E., & Rosenberg, S. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1167 · Cited by 660
Senzer, N. N., Kaufman, H. L., Amatruda, T., Nemunaitis, M., Reid, T., Daniels, G., Gonzalez, R., Glaspy, J., Whitman, E., Harrington, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.3675 · Cited by 616
Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., Guest, P. J., Harrington, K. J., James, N. D., Love, C. A., McNeish, I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0759 · Cited by 569
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Breitbach, C. J., Burke, J., Jonker, D., Stephenson, J., Haas, A. R., Chow, L. Q. M., Nieva, J., Hwang, T.-H., Moon, A., Patt, R., et al. (2011) · Nature · doi:10.1038/nature10358 · Cited by 551
Self-citationPark, B.-H., Hwang, T., Liu, T.-C., Sze, D. Y., Kim, J.-S., Kwon, H.-C., Oh, S. Y., Han, S.-Y., Yoon, J.-H., Hong, S.-H., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70107-4 · Cited by 521
Self-citationKaufman, H. L., Kim, D. W., DeRaffele, G., Mitcham, J., Coffin, R. S., & Kim-Schulze, S. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0809-6 · Cited by 518
Gene-engineered T cells for cancer therapy
Kershaw, M. H., Westwood, J. A., & Darcy, P. K. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3565 · Cited by 505
China Approves World's First Oncolytic Virus Therapy For Cancer Treatment
Garber, K. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj111 · Cited by 489
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Liu, T.-C., Galanis, E., & Kirn, D. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0736 · Cited by 450
Martins, I., Kepp, O., Schlemmer, F., Adjemian, S., Tailler, M., Shen, S., Michaud, M., Menger, L., Gdoura, A., Tajeddine, N., et al. (2011) · Oncogene · doi:10.1038/onc.2010.500 · Cited by 414
Marshall, J. L., Hoyer, R. J., Toomey, M. A., Faraguna, K., Chang, P., Richmond, E., Pedicano, J. E., Gehan, E., Peck, R. A., Arlen, P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.23.3964 · Cited by 357
Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
Mastrangelo, M. J., Maguire, H. C., Eisenlohr, L. C., Laughlin, C. E., Monken, C. E., McCue, P. A., Kovatich, A. J., & Lattime, E. C. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700066 · Cited by 353
Madan, R. A., Mohebtash, M., Arlen, P. M., Vergati, M., Rauckhorst, M., Steinberg, S. M., Tsang, K. Y., Poole, D. J., Parnes, H. L., Wright, J. J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70006-2 · Cited by 326
Parato, K. A., Breitbach, C. J., Le Boeuf, F., Wang, J., Storbeck, C., Ilkow, C., Diallo, J.-S., Falls, T., Burns, J., Garcia, V., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.276 · Cited by 305
Self-citationKim, J. H., Oh, J. Y., Park, B. H., Lee, D. E., Kim, J. S., Park, H. E., Roh, M. S., Je, J. E., Yoon, J. H., Thorne, S. H., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.008 · Cited by 303
Nemunaitis, J., Cunningham, C., Buchanan, A., Blackburn, A., Edelman, G., Maples, P., Netto, G., Tong, A., Randlev, B., Olson, S., et al. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301424 · Cited by 283
Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow
Breitbach, C. J., Paterson, J. M., Lemay, C. G., Falls, T. J., McGuire, A., Parato, K. A., Stojdl, D. F., Daneshmand, M., Speth, K., Kirn, D., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300215 · Cited by 277
Self-citationZelenay, S., Keller, A. M., Whitney, P. G., Schraml, B. U., Deddouche, S., Rogers, N. C., Schulz, O., Sancho, D., & Reis e Sousa, C. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60644 · Cited by 272
Oncolytic Immunovirotherapy for Melanoma Using Vesicular Stomatitis Virus
Diaz, R. M., Galivo, F., Kottke, T., Wongthida, P., Qiao, J., Thompson, J., Valdes, M., Barber, G., & Vile, R. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3974 · Cited by 264
Harrington, K. J., Hingorani, M., Tanay, M. A., Hickey, J., Bhide, S. A., Clarke, P. M., Renouf, L. C., Thway, K., Sibtain, A., McNeish, I. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0196 · Cited by 259
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Breitbach, C. J., Arulanandam, R., De Silva, N., Thorne, S. H., Patt, R., Daneshmand, M., Moon, A., Ilkow, C., Burke, J., Hwang, T.-H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2687 · Cited by 258
Self-citationTrial watch: Oncolytic viruses for cancer therapy
Vacchelli, E., Eggermont, A., Sautès-Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.24612 · Cited by 255
Monoclonal antibodies to phosphotyrosine
Glenney, J. R., Zokas, L., & Kamps, M. P. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90253-0 · Cited by 231
Cerullo, V., Pesonen, S., Diaconu, I., Escutenaire, S., Arstila, P. T., Ugolini, M., Nokisalmi, P., Raki, M., Laasonen, L., Särkioja, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3567 · Cited by 226
Miyamoto, S., Inoue, H., Nakamura, T., Yamada, M., Sakamoto, C., Urata, Y., Okazaki, T., Marumoto, T., Takahashi, A., Takayama, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3185 · Cited by 222
New viruses for cancer therapy: meeting clinical needs
Miest, T. S., & Cattaneo, R. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3140 · Cited by 220
Jäger, E., Karbach, J., Gnjatic, S., Neumann, A., Bender, A., Valmori, D., Ayyoub, M., Ritter, E., Ritter, G., Jäger, D., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606512103 · Cited by 216
Kaufman, H. L., & Bines, S. D. (2010) · Future Oncology · doi:10.2217/fon.10.66 · Cited by 209
Targeting Tumor Vasculature With an Oncolytic Virus
Breitbach, C. J., De Silva, N. S., Falls, T. J., Aladl, U., Evgin, L., Paterson, J., Sun, Y. Y., Roy, D. G., Rintoul, J. L., Daneshmand, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.26 · Cited by 204
Self-citationTargeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia Virus
Kirn, D. H., Wang, Y., Le Boeuf, F., Bell, J., & Thorne, S. H. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040353 · Cited by 203
Self-citationHodge, J. W., McLaughlin, J. P., Kantor, J. A., & Schlom, J. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00238-1 · Cited by 201
Odunsi, K., Matsuzaki, J., Karbach, J., Neumann, A., Mhawech-Fauceglia, P., Miller, A., Beck, A., Morrison, C. D., Ritter, G., Godoy, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117208109 · Cited by 200
Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients
Adair, R. A., Roulstone, V., Scott, K. J., Morgan, R., Nuovo, G. J., Fuller, M., Beirne, D., West, E. J., Jennings, V. A., Rose, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003578 · Cited by 192
Liu, T.-C., Hwang, T., Park, B.-H., Bell, J., & Kirn, D. H. (2008) · Molecular Therapy · doi:10.1038/mt.2008.143 · Cited by 189
Self-citationNguyên, T. L.-A., Abdelbary, H., Arguello, M., Breitbach, C., Leveille, S., Diallo, J.-S., Yasmeen, A., Bismar, T. A., Kirn, D., Falls, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803988105 · Cited by 182
Self-citationRegulation of IL-15 secretion via the leader peptide of two IL-15 isoforms
Onu, A., Pohl, T., Krause, H., & Bulfone-Paus, S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.255 · Cited by 180
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Bridle, B. W., Stephenson, K. B., Boudreau, J. E., Koshy, S., Kazdhan, N., Pullenayegum, E., Brunellière, J., Bramson, J. L., Lichty, B. D., & Wan, Y. (2010) · Molecular Therapy · doi:10.1038/mt.2010.98 · Cited by 176
Self-citationMaraba Virus as a Potent Oncolytic Vaccine Vector
Pol, J. G., Zhang, L., Bridle, B. W., Stephenson, K. B., Rességuier, J., Hanson, S., Chen, L., Kazdhan, N., Bramson, J. L., Stojdl, D. F., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2013.249 · Cited by 173
Self-citationT-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
Yu, F., Wang, X., Guo, Z. S., Bartlett, D. L., Gottschalk, S. M., & Song, X.-T. (2014) · Molecular Therapy · doi:10.1038/mt.2013.240 · Cited by 170
Epardaud, M., Elpek, K. G., Rubinstein, M. P., Yonekura, A.-R., Bellemare-Pelletier, A., Bronson, R., Hamerman, J. A., Goldrath, A. W., & Turley, S. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0045 · Cited by 167
Harrop, R., Connolly, N., Redchenko, I., Valle, J., Saunders, M., Ryan, M. G., Myers, K. A., Drury, N., Kingsman, S. M., Hawkins, R. E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2732 · Cited by 166
Hwang, T.-H., Moon, A., Burke, J., Ribas, A., Stephenson, J., Breitbach, C. J., Daneshmand, M., De Silva, N., Parato, K., Diallo, J.-S., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.132 · Cited by 159
Self-citationCerullo, V., Diaconu, I., Kangasniemi, L., Rajecki, M., Escutenaire, S., Koski, A., Romano, V., Rouvinen, N., Tuuminen, T., Laasonen, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.113 · Cited by 159
Heo, J., Breitbach, C. J., Moon, A., Kim, C. W., Patt, R., Kim, M. K., Lee, Y. K., Oh, S. Y., Woo, H. Y., Parato, K. A., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.39 · Cited by 156
Self-citationIrvine, K. R., Chamberlain, R. S., Shulman, E., Surman, D. R., Rosenberg, S. A., & Restifo, N. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1595 · Cited by 155
Smac mimetics and innate immune stimuli synergize to promote tumor death
Beug, S. T., Tang, V. A., LaCasse, E. C., Cheung, H. H., Beauregard, C. E., Brun, J., Nuyens, J. P., Earl, N., St-Jean, M., Holbrook, J., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2806 · Cited by 146
Self-citationBose, A., Taylor, J. L., Alber, S. M., Watkins, S. C., García, J. A., Rini, B. I., Ko, J. S., Cohen, P. A., Finke, J. H., & Storkus, W. J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25863 · Cited by 145
Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
Loi, S. (2013) · OncoImmunology · doi:10.4161/onci.24720 · Cited by 134
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
Curran, M. A., & Allison, J. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3289 · Cited by 132
Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
Li, J., O’Malley, M. E., Urban, J. A., Sampath, P., Guo, Z. S., Kaliński, P., Thorne, S. H., & Bartlett, D. L. (2011) · Molecular Therapy · doi:10.1038/mt.2010.312 · Cited by 131
Li, H., Peng, K.-W., Dingli, D., Kratzke, R. A., & Russell, S. J. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.10 · Cited by 130
Lee, Y., Kim, J.-H., Choi, K., Choi, I.-K., Kim, H., Cho, S., Cho, B. C., & Yun, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0935 · Cited by 125
Huang, J.-H., Zhang, S.-N., Choi, K., Choi, I.-K., Kim, J.-H., Lee, M., Kim, H., & Yun, C. (2009) · Molecular Therapy · doi:10.1038/mt.2009.205 · Cited by 124
Li, J., Liu, H., Xr, Z., Xu, J.-P., Hu, W.-K., Liang, M., Chen, S.-Y., Hu, F., & Chu, D.-T. (2008) · Gene Therapy · doi:10.1038/gt.2008.179 · Cited by 122
Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer
Kaufman, H. L., Lenz, H., Marshall, J. L., Singh, D., Garrett, C. R., Cripps, C., Moore, M. J., von Mehren, M., Dalfen, R., Heim, W. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0276 · Cited by 122
Andtbacka, R. H. I., Collichio, F. A., AMATRUDA, T. T., Senzer, N. N., Chesney, J. A., Delman, K. A., S̄pitler, L. E., Puzanov, I. J., Doleman, S., Ye, Y., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.lba9008 · Cited by 119
Post, D. E., Sandberg, E. M., Kyle, M. M., Devi, N. S., Brat, D. J., Xu, Z., Tighiouart, M., & Meir, E. G. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3244 · Cited by 119
Willmon, C. L., Saloura, V., Fridlender, Z. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1013 · Cited by 114
Terada, K., Wakimoto, H., Tyminski, E., Chiocca, E. A., & Saeki, Y. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302717 · Cited by 113
Moehler, M. H., Zeidler, M., Wilsberg, V., Cornelis, J. J., Woelfel, T., Rommelaere, J., Galle, P. R., & Heike, M. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.996 · Cited by 110
Varghese, S., Rabkin, S. D., Liu, R., Nielsen, P., Ipe, T. S., & Martuza, R. L. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700900 · Cited by 110
Kim, M. K., Breitbach, C. J., Moon, A., Heo, J., Lee, Y. K., Cho, M., Lee, J. W., Kim, S.-G., Kang, D. H., Bell, J. C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005361 · Cited by 110
Self-citationChoi, I.-K., Lee, J.-S., Zhang, S.-N., Park, J. H., Lee, K.-M., Sonn, C. H., & Yun, C.-O. (2011) · Gene Therapy · doi:10.1038/gt.2011.37 · Cited by 109
Sukkurwala, A. Q., Martins, I., Wang, Y., Schlemmer, F., Ruckenstuhl, C., Durchschlag, M., Michaud, M., Senovilla, L., Sistigu, A., Ma, Y., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.73 · Cited by 109
Fukuhara, H., Ino, Y., Kuroda, T., Martuza, R. L., & Todo, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2534 · Cited by 103
Lee, B. H., Hwang, D. M., Palaniyar, N., Grinstein, S., Philpott, D. J., & Hu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035812 · Cited by 102
A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers
Diallo, J., Bœuf, F. L., Lai, F. W., Cox, J. A., Vähä-Koskela, M. J. V., Abdelbary, H., MacTavish, H., Waite, K., Falls, T. J., Wang, J., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.67 · Cited by 102
Self-citationIno, Y., Saeki, Y., Fukuhara, H., & Todo, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1494 · Cited by 102
Morse, M. A., Chaudhry, A., Gabitzsch, E. S., Hobeika, A. C., Osada, T., Clay, T. M., Amalfitano, A., Burnett, B. K., Devi, G. R., Hsu, D. S., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1400-3 · Cited by 98
Fu, W., McCormick, T., Qi, X., Luo, L., Zhou, L., Li, X., Wang, B.-C., Gibbons, H. E., Abdul‐Karim, F. W., & Gorodeski, G. I. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-114 · Cited by 89
Todo, T., Martuza, R. L., Dallman, M. J., & Rabkin, S. D. (2001) · PubMed · Cited by 89
Recombinant viral vectors: Cancer vaccines
Harrop, R., John, J., & Carroll, M. W. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.05.005 · Cited by 88
Puzanov, I. J., Milhem, M. M., Andtbacka, R. H. I., Minor, D. R., Hamid, O., Li, A., Chastain, M. A., Gorski, K. S., Anderson, A., Vanderwalde, A. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.9029 · Cited by 88
Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
Vigil, A., Martinez, O., Chua, M. A., & García‐Sastre, A. (2008) · Molecular Therapy · doi:10.1038/mt.2008.181 · Cited by 87
Chang, J., Zhao, X., Wu, X., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.8.7913 · Cited by 87
Lapteva, N., Aldrich, M. B., Weksberg, D. C., Rollins, L. A., Goltsova, T., Chen, S. Y., & Huang, X. F. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318193d31e · Cited by 84
Huang, B., Sikorski, R. P., Kirn, D. H., & Thorne, S. H. (2010) · Gene Therapy · doi:10.1038/gt.2010.121 · Cited by 76
Näslund, T. I., Uyttenhove, C., Nordström, E. K. L., Colau, D., Warnier, G., Jondal, M., den Eynde, B. J. V., & Liljeström, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6761 · Cited by 74
Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy
Jha, B. K., Dong, B., Nguyen, C. T., Polyakova, I. V., & Silverman, R. H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.112 · Cited by 73
Liu, R. B., Engels, B., Schreiber, K., Ciszewski, C., Schietinger, A., Schreiber, H. W., & Jabrì, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301022110 · Cited by 70
Shin, E. J., Wanna, G. B., Choi, B. D., et al. (2007) · The Laryngoscope · doi:10.1097/01.mlg.0000246194.66295.d8 · Cited by 70
Su, C., Peng, L., Sham, J. S. T., Wang, X., Zhang, Q., Chua, D. T.-T., Liu, C., Cui, Z., Xue, H., Wu, H., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.12.011 · Cited by 64
Edukulla, R., Woller, N., Mundt, B., Knocke, S., Gürlevik, E., Saborowski, M., Malek, N. P., Manns, M. P., Wirth, T. C., Kühnel, F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1160 · Cited by 64
Targeting the tumor mutanome for personalized vaccination therapy
Kreiter, S., Castle, J. C., Türeci, Ö., & Şahin, U. (2012) · OncoImmunology · doi:10.4161/onci.19727 · Cited by 62
Shashkova, E. V., Spencer, J. F., Wold, W. S. M., & Doronin, K. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300064 · Cited by 62
Amato, R. J., Shingler, W. H., Naylor, S., Jac, J., Willis, J., Saxena, S., Hernandez-McClain, J., & Harrop, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0668 · Cited by 62
Evolution of Oncolytic Viruses: Novel Strategies for Cancer Treatment
Atherton, M. J., & Lichty, B. D. (2013) · Immunotherapy · doi:10.2217/imt.13.123 · Cited by 57
Self-citationKottke, T. J., Galivo, F., Wongthida, P., Díaz, R. M., Thompson, J., Jevremović, D., Barber, G. N., Hall, G. D., Chester, J. D., Selby, P. J., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.83 · Cited by 55
Kim, H. S., Kim‐Schulze, S., Kim, D. W., & Kaufman, H. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2522 · Cited by 52
Yoo, J. Y., Ryu, J., Gao, R., Yaguchi, T., Kaul, S. C., Wadhwa, R., & Yun, C. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1471 · Cited by 45
Robinson, M. J., Li, B., Ge, Y. C., Ko, D., Yendluri, S., Harding, T. A., VanRoey, M. J., Spindler, K. R., & Jooss, K. U. (2009) · Journal of Virology · doi:10.1128/jvi.02561-08 · Cited by 40
A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes
Hu, Z.-B., Wu, C., Wang, H., Zhang, Q.-W., Wang, L., Wang, R.-L., Lu, Z., & Wang, L. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701105 · Cited by 26
Correction: Oncolytic and Gene Therapy Using HYPR-Ad-IL4
(2007) · Cancer Research · doi:10.1158/0008-5472.can-67-17-cor1 · Cited by 26
Autophagy Mediates the Metabolic Benefits of Endurance Training
Galluzzi, L., & Kroemer, G. (2012) · Circulation Research · doi:10.1161/res.0b013e318259e70b · Cited by 6
Cited by
Management of glioblastoma: State of the art and future directions
Tan, A. C., Ashley, D. M., López, G. Y., Malinzak, M., Friedman, H. S., & Khasraw, M. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21613 · Cited by 1,972
Current state of immunotherapy for glioblastoma
Lim, M., Xia, Y., Bettegowda, C., & Weller, M. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0003-5 · Cited by 1,365
Gene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184
Cancer immunotherapy: the beginning of the end of cancer?
Farkona, S., Diamandis, E. P., & Blasutig, I. M. (2016) · BMC Medicine · doi:10.1186/s12916-016-0623-5 · Cited by 1,184
Immunological considerations for COVID-19 vaccine strategies
Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015
Self-citation
Metadata
- Authors
- Lichty, B. D., Breitbach, C. J., Stojdl, D. F., & Bell, J. C.
- Venue
- Nature Reviews Cancer
- Published
- 2014-07-03
- Volume
- 14
- Issue
- 8
- Pages
- 559-567
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2011513757
- Cited by
- 581
- References
- 111
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.